CTNext, founded in 2012 and based in Hartford, Connecticut, is an accelerator that supports technology and innovation-focused startups and early-stage businesses in the region. As a subsidiary of Connecticut Innovations, CTNext runs various programs designed to foster growth and development in the local entrepreneurial ecosystem. One of its notable initiatives is the Talent Bridge internship program, which provides grants to small businesses in Connecticut to help fund the hiring of student interns. This program aims to create a connection between small businesses and students, ultimately contributing to job creation within the state. Through its efforts, CTNext plays a vital role in nurturing innovation and supporting the growth of new ventures in Connecticut.
Clean Crop Technologies, based in Haydenville, Massachusetts, specializes in food processing solutions aimed at enhancing food safety and reducing food waste. The company has developed a proprietary technology known as 'Clean Current,' which utilizes cold plasma generated from electricity and air to eliminate molds, toxins, and pests from grains and nuts. This method not only improves crop yields but also extends the shelf life of perishable foods without compromising their quality. Clean Crop's innovative approach is designed to be energy efficient and scalable, making it effective against a wide range of contaminants while leaving no harmful residues. Founded in 2020, Clean Crop Technologies is committed to addressing the challenges of food safety and waste in agriculture.
Encapsulate specializes in automated tumor-on-a-chip technology, which allows for the growth and preservation of cancer cells outside the body. This innovative approach enables the creation of micro tumors from patients' cancer cells, facilitating the assessment of how these cells respond to various chemotherapy and biotherapy drugs. By evaluating the efficacy of treatments on an individualized basis, Encapsulate's technology aids oncologists in determining effective personalized treatment regimens for cancer patients, starting from the initial diagnosis. This method enhances the ability to tailor cancer therapies to the specific needs of each patient, thereby improving treatment outcomes.
Encapsulate specializes in automated tumor-on-a-chip technology, which allows for the growth and preservation of cancer cells outside the body. This innovative approach enables the creation of micro tumors from patients' cancer cells, facilitating the assessment of how these cells respond to various chemotherapy and biotherapy drugs. By evaluating the efficacy of treatments on an individualized basis, Encapsulate's technology aids oncologists in determining effective personalized treatment regimens for cancer patients, starting from the initial diagnosis. This method enhances the ability to tailor cancer therapies to the specific needs of each patient, thereby improving treatment outcomes.
Encaptiv Corporation, founded in 2017 and based in Stamford, Connecticut, develops a mobile-based audience engagement platform tailored for virtual, hybrid, and in-person presentations and events. The platform offers customizable software solutions that enhance presentation, sales, and marketing efforts, allowing users to interact with their audience through features such as polling, note-taking, and bookmarking. Additionally, Encaptiv's software analyzes user engagement by tracking interactions, which helps clients create custom-branded experiences informed by communication research. This functionality aims to maximize audience engagement and improve conversion rates during events.
In the Farmington, Connecticut area, Tunxis Community College has academic, workforce training, and personal enrichment courses for students with all sorts of different interests that can earn you an associate’s degree or certificate. Among the many majors to choose from are programs such as Allied Health, Graphic Design, Visual Fine Arts, Business Office Technology, Computer Information Systems, Criminal Justice, Drug and Alcohol Recovery Counselor, Early Childhood Education, Engineering Science and Technology Studies, and New Media Communication, as well as many more. Counselors in the financial aid office can point you toward programs that will help you earn loans, grants, scholarships, veteran’s benefits, and more if you qualify. These financial aid options can help you pay for tuition and other expenses. Student life at TCC includes a student lounge, The Cyber Café, and the Barnes-Franklin Gallery, which is filled with student, community, and professional art. Academic advising is available for any student who needs help. The career center can help students find employment. Other student resources includes child care, health care, media center, and student activities.
Verb Energy, Inc. is a manufacturer of caffeinated energy bars founded in 2015 and based in Lexington, Massachusetts. The company focuses on creating simple, healthy, and delicious energy products that cater to a wide audience. Its flagship offering, the Verb Caffeinated Energy Bar, incorporates caffeine sourced from organic green tea, combined with carbohydrates and protein to ensure prolonged caffeine absorption. This formulation aims to provide consumers with a convenient and effective source of long-lasting energy at an affordable price. Verb Energy emphasizes the importance of health and taste in its products, making them suitable for everyday consumption.
Vesselon is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of its encapsulated drug/drug platform technology. Furthermore, the complexes are formed at the time of administration (rather than at the drug manufacturing stage) enabling the creation of new complexes from already approved therapeutics. The company is developing a next-generation, multi-targeted encapsulated oncolytic virus complex that has been shown in preclinical models to be effective at low titers across a wide range of tumors. Also, the company is developing an encapsulated recombinant interleukin-2 complex targeting clinically relevant dosages to solid tumors with systemic exposure far below that which could cause adverse events. Vesselon’s proprietary complexes can be applied across a spectrum of cancers and other serious diseases in a variety of drug classes.
eBrevia, Inc. specializes in artificial intelligence-driven software designed for legal applications, including due diligence, contract management, lease abstraction, and document drafting. The company's offerings include the Diligence Accelerator, which helps attorneys efficiently navigate the due diligence process by extracting relevant content from legal documents and populating summary templates. Additionally, the eBrevia Contract Analyzer aids organizations in storing, retrieving, and analyzing contracts, while the Lease Abstractor streamlines the lease review process by highlighting pertinent information. eBrevia Bespoke further enhances this by identifying custom terms within legal documents. Founded in 2011 and headquartered in Stamford, Connecticut, with additional offices in San Francisco and New York, eBrevia serves law firms and corporate legal departments. The company has received recognition for its innovative technology, including awards from the Connecticut Technology Council and accolades at national competitions. eBrevia operates as a subsidiary of Donnelley Financial Solutions, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.